- Home
- BMR vs CTSO Comparison
BMR vs CTSO Comparison
Compare BMR & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- CTSO
- Stock Information
- Founded
- BMR 2009
- CTSO 1997
- Country
- BMR Israel
- CTSO United States
- Employees
- BMR N/A
- CTSO N/A
- Industry
- BMR Computer Software: Prepackaged Software
- CTSO Medical/Dental Instruments
- Sector
- BMR Technology
- CTSO Health Care
- Exchange
- BMR Nasdaq
- CTSO Nasdaq
- Market Cap
- BMR 59.3M
- CTSO 61.3M
- IPO Year
- BMR 2023
- CTSO N/A
- Fundamental
- Price
- BMR $2.34
- CTSO $1.00
- Analyst Decision
- BMR
- CTSO Strong Buy
- Analyst Count
- BMR 0
- CTSO 3
- Target Price
- BMR N/A
- CTSO $4.67
- AVG Volume (30 Days)
- BMR 100.8K
- CTSO 77.2K
- Earning Date
- BMR 04-15-2025
- CTSO 05-08-2025
- Dividend Yield
- BMR N/A
- CTSO N/A
- EPS Growth
- BMR N/A
- CTSO N/A
- EPS
- BMR N/A
- CTSO N/A
- Revenue
- BMR $3,064,000.00
- CTSO $35,594,520.00
- Revenue This Year
- BMR N/A
- CTSO $24.50
- Revenue Next Year
- BMR N/A
- CTSO $21.77
- P/E Ratio
- BMR N/A
- CTSO N/A
- Revenue Growth
- BMR 5.33
- CTSO 14.51
- 52 Week Low
- BMR $2.12
- CTSO $0.70
- 52 Week High
- BMR $8.42
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- BMR 42.21
- CTSO 44.01
- Support Level
- BMR $2.12
- CTSO $0.97
- Resistance Level
- BMR $2.85
- CTSO $1.05
- Average True Range (ATR)
- BMR 0.19
- CTSO 0.07
- MACD
- BMR 0.02
- CTSO -0.01
- Stochastic Oscillator
- BMR 30.14
- CTSO 17.53
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.